Please login to the form below

Emflaza

This page shows the latest Emflaza news and features for those working in and with pharma, biotech and healthcare.

to treat the symptoms of DMD – called Emflaza (deflazacort) – last year.

Mallinckrodt doses first patient in muscular dystrophy trial

but was rejected in the US, and novel steroid Emflaza (deflazacort) from Marathon Pharma.
FDA reviewer unimpressed with PTC’s Translarna

saying its commercial operations were already in gear following the FDA’s approval of Emflaza (deflazacort) for DMD earlier this year.
Connecting the dots

Not just any drug mind you - a decades-old corticosterioid called Emflaza (deflazacort) that is available elsewhere for about $1, 500 per year.
Marathon pauses Emflaza launch amid pricing furore

Marathon Pharmaceuticals is facing a backlash over plans to launch its just-approved steroid drug Emflaza - available for decades - at the princely sum of $89, 000 a year for Duchenne muscular ... In response, Marathon has said it is "pausing its
FDA approves first steroid for Duchenne muscular dystrophy

Marathon Pharma’s Emflaza is first approved to treat all genetic forms of the condition. ... Marathon insists that Emflaza causes fewer side effects than prednisone and so warrants premium pricing.

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Deal Watch March 2017

The other asset purchase agreement was made by PTC Therapeutics, who acquired Emflaza, a steroid approved for Duchenne Muscular Dystrophy, from Marathon Pharmaceuticals for $140m upfront ($75m in cash and $65m ... 230. Marathon. PTC Therapeutics. Product

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

AM / Senior Account Manager – Healthcare PR - London / Remote: Highly Competitive Salary, Bonus &Benefits

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

Entry Level Account Executive – Healthcare Advertising – London...: Salary TBC

FREELANCE Associate Director - Healthcare PR - Remote or London: Superb Day Rate &Benefits

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

Add my company

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Diversity in clinical trials: looking back at our 2021 blogs: In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...

Email:
Password: